Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of MMV390048 in Healthy Volunteers
NCT02783820Phase 1Completed
- Sponsor
- Medicines for Malaria Venture
- Start
- May 2016
- Primary completion
- Dec 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of MMV390048 in malaria, sponsored by Medicines for Malaria Venture. Started May 2016; status: completed.
02
Drugs
MMV390048
03
Conditions
malaria
Beyond the preview
Go deeper on NCT02783820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02783820.